ArticleJournal of clinical pharmacology2025

The Impact of Survival Benefit and Study Design on FDA Approval for Anticancer Drugs Over the Past Decades.

Koji Ishizuka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.